- 英
- insulin receptor substrate-1, IRS-1
- 関
- インスリン受容体基質
- 同
- insulin receptor substrate-1
WordNet
- the 9th letter of the Roman alphabet (同)i
PrepTutorEJDIC
- 『私は』私が
- iodineの化学記号
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/07/22 19:54:35」(JST)
[Wiki en表示]
Insulin receptor substrate 1 |
PDB rendering based on 1irs.
|
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1IRS, 1K3A, 1QQG, 2Z8C
|
|
|
Identifiers |
Symbols |
IRS1 ; HIRS-1 |
External IDs |
OMIM: 147545 MGI: 99454 HomoloGene: 4049 GeneCards: IRS1 Gene |
Gene ontology |
Molecular function |
• signal transducer activity
• transmembrane receptor protein tyrosine kinase adaptor activity
• protein kinase C binding
• insulin receptor binding
• insulin-like growth factor receptor binding
• protein binding
• SH2 domain binding
• phosphatidylinositol 3-kinase binding
|
Cellular component |
• nucleus
• cytoplasm
• cytosol
• plasma membrane
• insulin receptor complex
• caveola
• ciliary basal body
• intracellular membrane-bounded organelle
|
Biological process |
• positive regulation of mesenchymal cell proliferation
• signal transduction
• epidermal growth factor receptor signaling pathway
• positive regulation of cell proliferation
• insulin receptor signaling pathway
• fibroblast growth factor receptor signaling pathway
• regulation of gene expression
• positive regulation of glucose metabolic process
• phosphatidylinositol 3-kinase signaling
• lipid catabolic process
• positive regulation of cell migration
• mammary gland development
• positive regulation of fatty acid beta-oxidation
• response to insulin
• cellular response to insulin stimulus
• protein localization to nucleus
• Fc-epsilon receptor signaling pathway
• glucose homeostasis
• response to peptide hormone
• protein kinase B signaling
• positive regulation of phosphatidylinositol 3-kinase activity
• innate immune response
• positive regulation of glycogen biosynthetic process
• positive regulation of glucose import
• negative regulation of insulin receptor signaling pathway
• positive regulation of insulin receptor signaling pathway
• negative regulation of insulin secretion
• insulin-like growth factor receptor signaling pathway
• neurotrophin TRK receptor signaling pathway
• phosphatidylinositol-mediated signaling
• JAK-STAT cascade involved in growth hormone signaling pathway
• positive regulation of glucose import in response to insulin stimulus
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
3667 |
16367 |
Ensembl |
ENSG00000169047 |
ENSMUSG00000055980 |
UniProt |
P35568 |
P35569 |
RefSeq (mRNA) |
NM_005544 |
NM_010570 |
RefSeq (protein) |
NP_005535 |
NP_034700 |
Location (UCSC) |
Chr 2:
226.73 – 226.8 Mb |
Chr 1:
82.23 – 82.29 Mb |
PubMed search |
[1] |
[2] |
|
Insulin receptor substrate 1 (IRS-1) is a signalling adapter protein that in humans is encoded by the IRS-1 gene.[1] It contains a single pleckstrin homology (PH) domain at the N-terminus and a PTB domain ca. 40 residues downstream of this. Together with IRS2, IRS3 (pseudogene) and IRS4, it is homologous to the Drosophila protein chico, whose disruption extends the median lifespan of flies up to 48%.[2] Similarly, Irs1 mutant mice experience moderate life extension and delayed age-related pathologies.[3]
Contents
- 1 Function
- 2 Regulation
- 3 Interactions
- 4 References
- 5 Further reading
Function
Insulin receptor substrate 1 plays a key role in transmitting signals from the insulin and insulin-like growth factor-1 (IGF-1) receptors to intracellular pathways PI3K / Akt and Erk MAP kinase pathways.
Tyrosine phosphorylation of the insulin receptors or IGF-1 receptors, upon extracellular ligand binding, induces the cytoplasmic binding of IRS-1 to these receptors, through its PTB domains. Multiple tyrosine residues of IRS-1 itself are then phosphorylated by these receptors. This enables IRS-1 to activate several signalling pathways, including the PI3K pathway and the MAP kinase pathway.
IRS-1 plays important biological function for both metabolic and mitogenic (growth promoting) pathways: mice deficient of IRS1 have only a mild diabetic phenotype, but a pronounced growth impairment, i.e., IRS-1 knockout mice only reach 50% of the weight of normal mice. IRS-1 may also play a role in cancer, as it has been shown that transgenic mice overexpressing IRS-1 develop breast cancer.[4]
Regulation
The cellular protein levels of IRS-1 are regulated by the Cullin7 E3 ubiquitin ligase, which targets IRS-1 for ubiquitin mediated degradation by the proteasome.[5]
Interactions
IRS1 has been shown to interact with:
- Bcl-2,[6]
- Grb2,[7][8][9]
- INSR,[10][11]
- IGF1R,[12][13][14]
- JAK1,[15][16]
- JAK2,[15][17]
- MAPK8,[10][18]
- PIK3R1[8][19][20][21]
- PIK3R3,[22][23]
- PTK2,[24]
- PTPN11,[25][26]
- PTPN1,[27][28] and
- YWHAE.[29]
References
- ^ Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA et al. (Jul 1991). "Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein". Nature 352 (6330): 73–7. doi:10.1038/352073a0. PMID 1648180.
- ^ Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E et al. (Apr 2001). "Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein". Science 292 (5514): 104–6. doi:10.1126/science.1057991. PMID 11292874.
- ^ Selman C, Lingard S, Choudhury AI, Batterham RL, Claret M, Clements M et al. (Mar 2008). "Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice". FASEB Journal 22 (3): 807–18. doi:10.1096/fj.07-9261com. PMID 17928362.
- ^ Dearth RK, Cui X, Kim HJ, Kuiatse I, Lawrence NA, Zhang X et al. (Dec 2006). "Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2". Molecular and Cellular Biology 26 (24): 9302–14. doi:10.1128/MCB.00260-06. PMC 1698542. PMID 17030631.
- ^ Xu X, Sarikas A, Dias-Santagata DC, Dolios G, Lafontant PJ, Tsai SC et al. (May 2008). "The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation". Molecular Cell 30 (4): 403–14. doi:10.1016/j.molcel.2008.03.009. PMC 2633441. PMID 18498745.
- ^ Ueno H, Kondo E, Yamamoto-Honda R, Tobe K, Nakamoto T, Sasaki K et al. (Feb 2000). "Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function". Molecular Biology of the Cell 11 (2): 735–46. doi:10.1091/mbc.11.2.735. PMC 14806. PMID 10679027.
- ^ Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R et al. (May 1993). "The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling". The EMBO Journal 12 (5): 1929–36. PMC 413414. PMID 8491186.
- ^ a b Morrison KB, Tognon CE, Garnett MJ, Deal C, Sorensen PH (Aug 2002). "ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation". Oncogene 21 (37): 5684–95. doi:10.1038/sj.onc.1205669. PMID 12173038.
- ^ Giorgetti-Peraldi S, Peyrade F, Baron V, Van Obberghen E (Dec 1995). "Involvement of Janus kinases in the insulin signaling pathway". European Journal of Biochemistry / FEBS 234 (2): 656–60. doi:10.1111/j.1432-1033.1995.656_b.x. PMID 8536716.
- ^ a b Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF (Jan 2002). "Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action". The Journal of Biological Chemistry 277 (2): 1531–7. doi:10.1074/jbc.M101521200. PMID 11606564.
- ^ Sawka-Verhelle D, Tartare-Deckert S, White MF, Van Obberghen E (Mar 1996). "Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786". The Journal of Biological Chemistry 271 (11): 5980–3. doi:10.1074/jbc.271.11.5980. PMID 8626379.
- ^ Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E (Oct 1995). "Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system". The Journal of Biological Chemistry 270 (40): 23456–60. doi:10.1074/jbc.270.40.23456. PMID 7559507.
- ^ Dey BR, Frick K, Lopaczynski W, Nissley SP, Furlanetto RW (Jun 1996). "Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10". Molecular Endocrinology 10 (6): 631–41. doi:10.1210/mend.10.6.8776723. PMID 8776723.
- ^ Mañes S, Mira E, Gómez-Mouton C, Zhao ZJ, Lacalle RA, Martínez-A C (Apr 1999). "Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility". Molecular and Cellular Biology 19 (4): 3125–35. PMC 84106. PMID 10082579.
- ^ a b Gual P, Baron V, Lequoy V, Van Obberghen E (Mar 1998). "Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor". Endocrinology 139 (3): 884–93. doi:10.1210/endo.139.3.5829. PMID 9492017.
- ^ Johnston JA, Wang LM, Hanson EP, Sun XJ, White MF, Oakes SA et al. (Dec 1995). "Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases". The Journal of Biological Chemistry 270 (48): 28527–30. doi:10.1074/jbc.270.48.28527. PMID 7499365.
- ^ Kawazoe Y, Naka T, Fujimoto M, Kohzaki H, Morita Y, Narazaki M et al. (Jan 2001). "Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation". The Journal of Experimental Medicine 193 (2): 263–9. doi:10.1084/jem.193.2.263. PMC 2193341. PMID 11208867.
- ^ Aguirre V, Uchida T, Yenush L, Davis R, White MF (Mar 2000). "The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)". The Journal of Biological Chemistry 275 (12): 9047–54. doi:10.1074/jbc.275.12.9047. PMID 10722755.
- ^ Hadari YR, Tzahar E, Nadiv O, Rothenberg P, Roberts CT, LeRoith D et al. (Sep 1992). "Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers". The Journal of Biological Chemistry 267 (25): 17483–6. PMID 1381348.
- ^ Gual P, Gonzalez T, Grémeaux T, Barres R, Le Marchand-Brustel Y, Tanti JF (Jul 2003). "Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes". The Journal of Biological Chemistry 278 (29): 26550–7. doi:10.1074/jbc.M212273200. PMID 12730242.
- ^ Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P et al. (May 2002). "An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events". Diabetologia 45 (5): 657–67. doi:10.1007/s00125-002-0798-5. PMID 12107746.
- ^ Xia X, Serrero G (Aug 1999). "Multiple forms of p55PIK, a regulatory subunit of phosphoinositide 3-kinase, are generated by alternative initiation of translation". The Biochemical Journal. 341 ( Pt 3) (3): 831–7. doi:10.1042/0264-6021:3410831. PMC 1220424. PMID 10417350.
- ^ Mothe I, Delahaye L, Filloux C, Pons S, White MF, Van Obberghen E (Dec 1997). "Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins". Molecular Endocrinology 11 (13): 1911–23. doi:10.1210/mend.11.13.0029. PMID 9415396.
- ^ Lebrun P, Mothe-Satney I, Delahaye L, Van Obberghen E, Baron V (Nov 1998). "Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125(FAK) and pp60(src)". The Journal of Biological Chemistry 273 (48): 32244–53. doi:10.1074/jbc.273.48.32244. PMID 9822703.
- ^ Kuhné MR, Pawson T, Lienhard GE, Feng GS (Jun 1993). "The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp". The Journal of Biological Chemistry 268 (16): 11479–81. PMID 8505282.
- ^ Myers MG, Mendez R, Shi P, Pierce JH, Rhoads R, White MF (Oct 1998). "The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling". The Journal of Biological Chemistry 273 (41): 26908–14. doi:10.1074/jbc.273.41.26908. PMID 9756938.
- ^ Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M (Feb 2000). "Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein". The Journal of Biological Chemistry 275 (6): 4283–9. doi:10.1074/jbc.275.6.4283. PMID 10660596.
- ^ Ravichandran LV, Chen H, Li Y, Quon MJ (Oct 2001). "Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor". Molecular Endocrinology 15 (10): 1768–80. doi:10.1210/mend.15.10.0711. PMID 11579209.
- ^ Craparo A, Freund R, Gustafson TA (Apr 1997). "14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner". The Journal of Biological Chemistry 272 (17): 11663–9. doi:10.1074/jbc.272.17.11663. PMID 9111084.
Further reading
- Jiang H, Harris MB, Rothman P (Jun 2000). "IL-4/IL-13 signaling beyond JAK/STAT". The Journal of Allergy and Clinical Immunology 105 (6 Pt 1): 1063–70. doi:10.1067/mai.2000.107604. PMID 10856136.
- Bezerra RM, Chadid TT, Altemani CM, Sales TS, Menezes R, Soares MC et al. (Feb 2004). "Lack of Arg972 polymorphism in the IRS1 gene in Parakanã Brazilian Indians". Human Biology 76 (1): 147–51. doi:10.1353/hub.2004.0015. PMID 15222685.
- Gibson SL, Ma Z, Shaw LM (Mar 2007). "Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis". Cell Cycle 6 (6): 631–7. doi:10.4161/cc.6.6.3987. PMID 17361103.
- Dearth RK, Cui X, Kim HJ, Hadsell DL, Lee AV (Mar 2007). "Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2". Cell Cycle 6 (6): 705–13. doi:10.4161/cc.6.6.4035. PMID 17374994.
PDB gallery
|
|
|
1irs: IRS-1 PTB DOMAIN COMPLEXED WITH A IL-4 RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE
|
|
1qqg: CRYSTAL STRUCTURE OF THE PH-PTB TARGETING REGION OF IRS-1
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Molecular pathways for glucose homeostasis, insulin signaling and autophagy in hepatitis C virus induced insulin resistance in a cellular model.
- Das GC, Hollinger FB.SourceDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States. Electronic address: gcdas@bcm.edu.
- Virology.Virology.2012 Dec 5;434(1):5-17. doi: 10.1016/j.virol.2012.07.003. Epub 2012 Aug 3.
- Chronic HCV infection induces insulin resistance (IR). We studied this in a persistently infected cell line with defects in glucose homeostasis resulting from the phosphorylation of glycogen synthase (GS Ser641) and GS kinase isoform 3β (GSK 3βSer9). Reversal of these effects in cells cured of HCV
- PMID 22862962
- Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance.
- Nakamura A, Tajima K, Zolzaya K, Sato K, Inoue R, Yoneda M, Fujita K, Nozaki Y, Kubota KC, Haga H, Kubota N, Nagashima Y, Nakajima A, Maeda S, Kadowaki T, Terauchi Y.SourceDepartment of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
- Diabetologia.Diabetologia.2012 Dec;55(12):3382-91. doi: 10.1007/s00125-012-2703-1. Epub 2012 Sep 7.
- AIMS/HYPOTHESIS: Epidemiological studies have revealed that obesity and diabetes mellitus are independent risk factors for the development of non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. However, the debate continues on whether insulin resistance as such is directly associated
- PMID 22955994
Japanese Journal
- メタボリックシンドローム発症基盤としてのインスリン抵抗性 臓器別インスリン抵抗性とその病態生理学的意義 脂肪細胞におけるインスリン抵抗性 (メタボリックシンドローム(第2版)--基礎・臨床の最新知見) -- (成因と病態生理)
- Gene up-regulation in response to predator kairomones in the water flea, Daphnia pulex
- Miyakawa Hitoshi,Imai Maki,Sugimoto Naoki,Ishikawa Yuki,Ishikawa Asano,Ishigaki Hidehiko,Okada Yasukazu,Miyazaki Satoshi,Koshikawa Shigeyuki,Cornette Richard,Miura Toru
- BMC Developmental Biology 10, 45, 2010-04-30
- … In addition, the juvenile hormone pathway genes, JHAMT and Met, and the insulin signaling pathway genes, InR and IRS-1, were up-regulated in the first-instar stage. …
- NAID 120002277519
Related Links
- そのリン酸化チロシンにインスリンレセプター基質1(IRS 1)が結合し,このIRS1がリン酸化される.リン酸化されたIRS1はホスファチジルイノシトール(PI)-3-キナーゼ(PI-3kinase)に結合し活性化をおこす.活性化されたPI-3キナーゼは を ...
- 米国CST社の日本法人CSTジャパン株式会社【公式サイト】Phospho-IRS-1 (Ser612) Antibodyページ。高品質の研究用試薬、米国本社の開発研究者による技術的サポートをご提供しております。
Related Pictures
★リンクテーブル★
[★]
- 英
- insulin-resistant, insulin resistance
- 関
- インスリン
定義
- 組織におけるインスリン作用の発現が十分になされない状態。
病態生理
- インスリン抵抗性はcommon disease発症と関連がある。糖尿病、高脂血症、高血圧、動脈硬化などと関係がある。
- 脂肪細胞によるTNFα過剰分泌やアディポネクチンの分泌低下がインスリン抵抗性と関係があるらしい。
- TNFαはIRS-1のチロシンリン酸化を抑制してsingnal transduction↓
- 高インスリン血症→交感神経の興奮・血管平滑筋の過形成(インスリンの作用、血管平滑筋のPDGFに対する感受性の増大)→血管抵抗性の増大→高血圧 (PHD.317)
- PDGFには血管平滑筋の成長因子としても作用する (PHD.317)
- インスリン抵抗性は骨格筋や肝臓内の脂肪酸過剰と関係がある。チアゾリジン薬は肝臓の脂肪含量を低下させる作用がある。(DMR.112)
妊娠とインスリン抵抗性 (NGY.297)
- hPLの作用。またhPLは遊離脂肪酸を増加させ、プロゲステロン、エストロゲンもこれに関わっているとされる。インスリン抵抗性は妊娠中期より上昇し始め、妊娠末期には初期の4倍となる
[★]
- 英
- insuline receptor
- 関
- インスリン、インスリン製剤
- チロシンキナーゼ
- αサブユニット2つ、βサブユニット2つからなる
- αとβがジスルフィド結合によりヘテロダイマーを形成し、さらに2つのαβ複合体がジスルフィド結合によりヘテロトリマーを形成している。
- 細胞内でIRS-1をリン酸化してシグナル伝達を行っている。
臨床関連
[★]
- 英
- insulin receptor substrate, IRS
- 関
- インスリン
[★]
- 英
- [[]]
- 同
- IRS-1
- 関
- [[]]
- 同
- IRS-1
[★]
[★]
- 同
- Intergroup Rhabdomyosarcoma Study
[★]